Drupal.behaviors.print = function(context) {window.print();window.close();}>
Q&A: Reisa Sperling on the Role of Protein Biomarkers in Alzheimer’s Drug Development
December 02, 2011
Q&A: Reisa Sperling on the Role of Protein Biomarkers in Alzheimer’s Drug Development
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
New Alzheimer's Guidelines Call for Use of Protein Biomarkers in Clinical Research
April 22, 2011 / ProteoMonitor
NIA Study Demonstrates ApoE's Potential as Blood-Based Protein Biomarker for Alzheimer's
December 24, 2010 / ProteoMonitor
AD Working Group Proposes New Alzheimer's Definition to Include Protein Biomarkers
October 15, 2010 / ProteoMonitor
Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor
Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor